0001209191-22-034820.txt : 20220607
0001209191-22-034820.hdr.sgml : 20220607
20220607160710
ACCESSION NUMBER: 0001209191-22-034820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Mark
CENTRAL INDEX KEY: 0001658379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 221001292
MAIL ADDRESS:
STREET 1: 25 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001658379
Coleman Mark
C/O AXSOME THERAPEUTICS, INC.
22 CORTLANDT STREET, 16TH FLOOR
NEW YORK
NY
10007
1
0
0
0
Stock Option (Right to Buy)
25.53
2022-06-03
4
A
0
16976
0.00
A
2023-06-03
2032-06-03
Common Stock
16976
16976
D
The option vests in full on the one-year anniversary of the date of grant, June 3, 2023.
/S/ Herriot Tabuteau, M.D., Attorney-in-Fact
2022-06-07